Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuromuscular Fatigability in Multiple Sclerosis (FatSEP)
NCT03983720Phase 2Terminated
- Sponsor
- CHU Saint-Etienne
- Start
- Jan 2020
- Primary completion
- Jun 2021
- Countries
- 1
01
Overview
Phase 2, open-label trial (3 arms), sponsored by CHU Saint-Etienne. Primary endpoint: Voluntary maximum contraction at Day 30. Started Jan 2020; status: terminated.
Beyond the preview
Go deeper on NCT03983720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03983720.